Back to Search Start Over

Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease

Authors :
Anna Castrioto
Bettina Debû
Emilie Cousin
Pierre Pelissier
Eugénie Lhommée
Amélie Bichon
Emmanuelle Schmitt
Andrea Kistner
Sara Meoni
Eric Seigneuret
Stephan Chabardes
Paul Krack
Elena Moro
Valérie Fraix
COUSIN, EMILIE
Centre Hospitalier Universitaire [Grenoble] (CHU)
[GIN] Grenoble Institut des Neurosciences (GIN)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes (UGA)
IRMaGe (IRMaGe)
CHU Grenoble-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)
Laboratoire de Psychologie et NeuroCognition (LPNC )
Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)
CHU Grenoble
Bern University Hospital [Berne] (Inselspital)
Source :
European Journal of Neurology, European Journal of Neurology, 2022, 29 (9), pp.2645-2653. ⟨10.1111/ene.15436⟩
Publication Year :
2022
Publisher :
Wiley, 2022.

Abstract

International audience; Background and purpose: Studies on long-term nonmotor outcomes of subthalamic nucleus stimulation in Parkinson disease (PD) are scarce. This study reports on very long-term non-motor and motor outcomes in one of the largest cohorts of people with advanced PD, treated for >10 years with subthalamic nucleus stimulation. The main outcome was to document the evolution of independence in activities of daily living. The secondary outcomes were to measure the change in quality of life, as well as non-motor and motor outcomes.Methods: Patients were studied preoperatively, at 1 year, and beyond 10 years after subthalamic stimulation with an established protocol including motor, non-motor, and neuropsychological assessments.Results: Eighty-five people with PD were included. Independence scores in the off-medication condition (measured with the Schwab & England Activities of Daily Living Scale) as well as quality of life (measured with the Parkinson's Disease Questionnaire [PDQ]-37) remained improved at longest follow-up compared to preoperatively (respectively, p < 0.001, p = 0.015). Cognitive scores, measured with the Mattis Dementia Rating Scale, significantly worsened compared to before and 1 year after surgery (p < 0.001), without significant change in depression, measured with the Beck Depression Inventory. Motor fluctuations, dyskinesias, and off dystonia remained improved at longest follow-up (p < 0.001), with a significant reduction in dopaminergic treatment (45%, p < 0.001).Conclusions: This study highlights the long-term improvement of subthalamic stimulation on independence and quality of life, despite the progression of disease and the occurrence of levodopa-resistant symptoms.

Details

ISSN :
14681331 and 13515101
Volume :
29
Database :
OpenAIRE
Journal :
European Journal of Neurology
Accession number :
edsair.doi.dedup.....8c88597b3601ac898066af4c57b7704d
Full Text :
https://doi.org/10.1111/ene.15436